Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jun, 2014 | Pages:
99 | Publisher: Netscribes
Industry: Healthcare | Report Format: Electronic (PDF)
Netscribes' latest market research report titled Cardiovascular Pharmaceutical Market in India 2014 highlights the analysis of the drivers and explains the factors for growth of the industry. Increasing patient population, patent expiry of blockbuster drugs, and introduction of newer and better drugs are the key drivers of this market. Cardiovascular pharmaceuticals is one of the leading therapeutic segments of the overall pharma industry and cardiovascular diseases (CVDs) are the top causes of deaths worldwide Growing incidences of cardiovascular diseases is helping the Indian market to grow and large pharmaceutical companies are trying to launch new patented blockbuster drugs to tackle the situation. Patented blockbuster drugs, after becoming generic, present a huge opportunity for growth. Generic drugs increase the affordability among patients, which helps in the growth of the market. The increasing disposable income of people are also helping to boost the market size. Some challenges faced by the industry are the internal competition between large pharmaceutical companies and competition from complementary and alternative medicines. Various government initiatives have been undertaken to reduce the drug prices and various tax reforms and control programs are promoting the growth of the market as well
Table of Contents
Slide 1: Executive Summary Macroeconomic Indicators Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jun 2013 - Nov 2013) Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013), Exchange Rate: Half Yearly (Oct 2013 - March 2014) Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2010-11, 2011-12, 2012-13, 2013-14), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13) Introduction Slide 5: Major Drug Classes Market Overview Slide 6-7: Global Cardiovascular Pharmaceutical Market - Overview, Indian Cardiovascular Pharmaceutical Market - Overview, Market Size & Growth (2013-2018e) Value Chain Slide 8-9: Market Value Chain Analysis Drivers & Challenges Slide 10: Drivers and Challenges - Summary Slide 11-14: Drivers Slide 15: Challenges Government Initiatives Slide 16: Government Initiatives - Summary Slide 17: National List of Essential Medicines (NLEM), Jan Aushadhi Stores (JAS) Slide 18: Various tax reforms and control programmes Slide 19-20: Licensing and registration of pharmaceuticals Slide 21: Various other regulatory frameworks Slide 22: Patent Expiry - Cardiovascular Drugs Competitive Landscape Slide 23: Porter's Five Forces Analysis Slide 24: Public Trading Comparables, Top 4 Companies Slide 25-27: Competitive Benchmarking, Key Ratios of Top 3 Companies - Operational Basis (FY 2013) Slide 28: Competitive Benchmarking, Key Ratios of Top 3 Companies - Financial Basis (FY 2013) Slide 29-76: Major Public Players Slide 77-95: Major Private Players Recent Developments Slide 96: Recent Developments Strategic Recommendation Slide 97: Strategies Appendix Slide 98: Key Ratios Description Slide 99: Sources of Information
List of Tables
Market Overview 1. Top Selling Cardiovascular Drugs (2012) Market Segmentation 1. Raw Materials Used For Poultry Feed 2. Raw Materials Used For Aqua Feed Drivers & Challenges 1. Patent Expiry Date of drugs Regulation & Patents 1. Patent Expiry - Cardiovascular Drugs Competitive Landscape 1. Public Trading Comparables 2. Company Profiles (All Companies) a. Company Information (All Companies) b. Products and Services (All Companies) c. Key People (All Companies) d. Shareholders of the Company (All Companies) e. Key Financial Performance Indicators (Public Companies) f. Key Ratios (All Companies) g. Business Highlights (All Companies) Recent Developments 1. Recent developments Appendix 1. Key Ratios Description 2. Sources of Information
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
